A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Skyline Therapeutics
- Study ID
- NCT06346600
- Status
- Recruiting
Conditions
- Neovascular (Wet) Age-related Macular Degeneration
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- SKG0106 — GENETICNon-interventional (observational) study, long-term follow-up safety and efficacy assessments up to 5 years post SKG0106 injection.
Study Details
This is a Prospective, Non-interventional, Multicenter, Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients with Neovascular (Wet) Age-related Macular Degeneration (nAMD). All subject who completed the parent clinical study (NCT06213038 and NCT05986864) will undergo safety and efficacy assessments up to 5 years post study drug injection.
Key Dates
- Start date
- Apr 2, 2024
- Status verified
- Apr 2024
- Primary completion
- Mar 31, 2031
- Completion
- Mar 31, 2031
Study Design
- Enrollment
- 83 participants (estimated)
Arms
- Arm: Long-term Follow-Up of Participants exposed to SKG0106 Dose level 1No investigational product will be administered in this study.
- Arm: Long-term Follow-Up of Participants exposed to SKG0106 Dose level 2No investigational product will be administered in this study.
- Arm: Long-term Follow-Up of Participants exposed to SKG0106 Dose level 3No investigational product will be administered in this study.
Primary Outcome Measure
Type, severity, and incidence of ocular and systemic adverse events (AEs), serious adverse events (SAEs), and adverse events of special interest (AESIs) [ Time Frame: 5 years post study drug injection ]
Central Contacts
- Yongqin Wang+86 18616737445
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | - |
| Retina Consultants of Texas | Katy | Texas | 77494 | - |
| Wagner Macula & Retina Center | Norfolk | Virginia | 23502 | - |
Find similar trials in Boston, MA
Related Studies
- 4D-150 in Patients With Neovascular (Wet) Age-Related Macular DegenerationPHASE1/PHASE2 · Recruiting · 4D Molecular Therapeutics · Phoenix, Arizona
- Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular DegenerationPHASE1/PHASE2 · Recruiting · Eyconis INC. · Beverly Hills, California